MedPath
NMPA Approval

Dimenhydrinate Tablets

国药准字H45021214

August 18, 2020

国药准字H45021214

Drug Information

茶苯海明片

片剂

25mg

化学药品

August 18, 2020

Company Information

Applicant Company

桂林市七里店路43号

Manufacturing Company

桂林市七里店路43号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

茶苯海明片 - NMPA 批准文号 | MedPath